The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Alka-Seltzer Gold
Alka-Seltzer Gold · CITRIC ACID MONOHYDRATE 1000 mg/1; POTASSIUM BICARBONATE 344 mg/1; SODIUM BICARBONATE 1050 mg/1 · Tablet, Effervescent · Oral · Bayer HealthCare LLC.
NDC 00280-4100-63 · 18 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M001
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Alka-Seltzer Gold (Tablet, Effervescent)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bayer HealthCare LLC. | CITRIC ACID MONOHYDRATE 1000 mg/1; POTASSIUM BICARBONATE 344 mg/1; SODIUM BICARBONATE 1050 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Alka-Seltzer Gold — NDC 00280-4100-63," retrieved September 3, 2026, https://drugdashboards.com/drug/00280410063.
Free to cite with attribution — see how the data is put together.